Zdrowie i gospodarka · 27/03/2015
FDA Requests Public Comment on Proposed Clinical Trial Data Monitoring Committees
The Food and Drug Administration (FDA) is seeking public input on its proposed collection of information regarding the establishment and operation of clinical trial data monitoring committees, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →